Polaris Genomics
PrivateLast Round
Debt
Sep 3, 2025
Total Funding Raised
$5.66M
Company Overview
Polaris Genomics operates in Healthcare & Life Sciences and is based in Gaithersburg, Maryland. Its latest recorded funding round was a Debt round in September 2025.
Polaris Genomics is a biotechnology company that develops AI-powered genomic diagnostics and therapeutics for mental health and neuropsychiatric conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Polaris Genomics Comparables
Compare Polaris Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivid Genomics | 81% | |
| Circular Genomics | 78% | |
| MindX Sciences | 78% |
For institutional investors. Book with your work email.
Polaris Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 3, 2025 | ||||
| Seed | Nov 1, 2023 | ||||
| Grant | Nov 2, 2022 | ||||
| Grant | Sep 20, 2022 | ||||
| Grant | Jul 19, 2022 | ||||
Grant | Jan 5, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Polaris Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | Seed |
| Wavemaker Three-Sixty Health | Seed |
| Maryland Industrial Partnerships (MIPS) | Grant |
| Viking Global Investors | Seed |
| AFVentures | Grant |
| Illumina Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors increased 87% MoM.
- Sep 3, 2025
$250K debt round completed.
For institutional investors. Book with your work email.
Polaris Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Polaris Genomics's valuation, stock price, and market status.
Is Polaris Genomics a public or private company?
Polaris Genomics is a private company.
What is the current stock price of Polaris Genomics?
Polaris Genomics is a private company, so its shares have no public market price. Caplight tracks Polaris Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Polaris Genomics worth (valuation)?
Valuation information for Polaris Genomics is not publicly available.
Can I buy Polaris Genomics stock?
Polaris Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Polaris Genomics's last funding round?
Polaris Genomics's most recent funding round was Debt on September 3, 2025.
Who are the main investors in Polaris Genomics?
Key investors in Polaris Genomics include Illumina Accelerator.
Will Polaris Genomics IPO soon?
No public IPO plans have been announced for Polaris Genomics.
How can I track Polaris Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Polaris Genomics's shares on secondary markets.